Nicoleta Sinevici

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance”.

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance

Frontiers in Oncology(2020)10.3389/fonc.2020.554704

N/A

0DataRank · unranked

13 citations

Bahar Ataeinia, Veronica Zehnder, Kevin Lin, Lauren Grove, Pedram Heidari +2 more

Non-invasive Detection of Immunotherapy-Induced Adverse Events

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4641

N/A

0DataRank · unranked

1 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide

Pharmaceutics(2022)10.3390/pharmaceutics14071460

N/A

0DataRank · unranked

13 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Alyssa Granito, Hritik Mahajan Kumar +3 more

Data from Non-invasive Detection of Immunotherapy-Induced Adverse Events

(2023)10.1158/1078-0432.c.6530544

N/A

0DataRank · unranked

0 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

Data from Non-invasive Detection of Immunotherapy-Induced Adverse Events

(2023)10.1158/1078-0432.c.6530544.v1

N/A

0DataRank · unranked

0 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance

Breast Cancer Research(2024)10.1186/s13058-024-01859-w

N/A

0DataRank · unranked

4 citations

Christine E. Edmonds, Brian N. Dontchos, Gary Wang, Constance D. Lehman, Steven J. Isakoff +2 more